Trials / Completed
CompletedNCT03189303
Cup Position in THA With Standard Instruments
Planned vs. Actual Acetabular Cup Position in Total Hip Arthroplasty With Standard Instrumentation and Technique
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 183 (actual)
- Sponsor
- DePuy Orthopaedics · Industry
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
Prospective, global, multicenter study to assess cup position in THA. After written informed consent has been obtained, study evaluations will be collected from the pre-op clinic visit, the operative visit (including discharge), and 6 and 12 weeks postoperatively.
Detailed description
This is a global, prospective, multi-center study with a planned analysis of a minimum of 176 Subjects. Up to 15 study sites will participate in this study. The primary and secondary endpoints are as follows: Primary endpoint: The primary endpoint is acetabular cup position success at 6 weeks postoperatively. Success is defined as cup inclination and version within 10 degrees of the plan. Secondary endpoints: 1. Inclination success (as defined for the primary endpoint) 2. Version success (as defined for the primary endpoint) 3. 90-day complication rates 4. Change from preoperative baseline for the Harris Hip Score 5. Radiographic Outcomes (based upon: AP Hip, AP Pelvis, and Modified Lauenstein Lateral) 6. Change from preoperative baseline for the EQ-5D-5L (health state, EQ-VAS, and index value, if applicable) 7. Change from 6 week baseline for the Forgotten Joint Score
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Primary Uncemented Total Hip Arthroplasty | The study devices are the Pinnacle Hip System acetabular cup with a Summit, Actis, or Corail femoral stem |
Timeline
- Start date
- 2017-09-07
- Primary completion
- 2021-05-19
- Completion
- 2021-12-14
- First posted
- 2017-06-16
- Last updated
- 2022-02-15
Locations
11 sites across 4 countries: United States, Italy, Netherlands, United Kingdom
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03189303. Inclusion in this directory is not an endorsement.